PHIO
Price:
$1.07
Market Cap:
$12.43M
Phio Pharmaceuticals Corp. is a U.S.-based company dedicated to creating immune-system-focused cancer treatments. Their proprietary INTASYL therapeutic platform aims to influence both tumor and immune cells through the precise regulation of immune system genes. The company's pipeline includes several key candidates for adoptive cell transfer (ACT): PH-762 works by diminishing the expression of the PD-1 checkpoint protein, thereby empowering immune cells to identify and eliminate cancerous cells; PH-894, another candidate, silences BRD4, an epigenetic protein crucial for intracellular gene expression regulation; and PH-804 is designed to target TIGIT, a suppressive immune receptor and checkpo...[Read more]
Industry
Biotechnology
IPO Date
2012-05-10
Stock Exchange
NASDAQ
Ticker
PHIO
According to Phio Pharmaceuticals Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -0.78. This represents a change of -36.19% compared to the average of -1.22 of the last 4 quarters.
The mean historical PE Ratio of Phio Pharmaceuticals Corp. over the last ten years is -0.62. The current -0.78 PE Ratio has changed 12.44% with respect to the historical average. Over the past ten years (40 quarters), PHIO's PE Ratio was at its highest in in the December 2024 quarter at -0.22. The PE Ratio was at its lowest in in the June 2021 quarter at -2.84.
Average
-0.62
Median
-0.51
Minimum
-1.40
Maximum
-0.15
Discovering the peaks and valleys of Phio Pharmaceuticals Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 264.39%
Maximum Annual PE Ratio = -0.15
Minimum Annual Increase = -78.05%
Minimum Annual PE Ratio = -1.40
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.72 | 264.39% |
| 2024 | -0.20 | 35.83% |
| 2023 | -0.15 | -66.95% |
| 2022 | -0.44 | -54.23% |
| 2021 | -0.96 | -31.18% |
| 2020 | -1.40 | 188.42% |
| 2019 | -0.49 | 54.23% |
| 2018 | -0.32 | -68.69% |
| 2017 | -1.01 | 87.97% |
| 2016 | -0.54 | -78.05% |
The current PE Ratio of Phio Pharmaceuticals Corp. (PHIO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.36
5-year avg
-0.49
10-year avg
-0.62
Phio Pharmaceuticals Corp.’s PE Ratio is less than TransCode Therapeutics, Inc. (-0.12), greater than Kiora Pharmaceuticals, Inc. (-0.96), less than IN8bio, Inc. (-0.33), greater than BioCardia, Inc. (-1.22), less than Aprea Therapeutics, Inc. (-0.44), greater than Marker Therapeutics, Inc. (-2.45), less than Galecto, Inc. (-0.12), greater than Creative Medical Technology Holdings, Inc. (-1.39), less than Acurx Pharmaceuticals, Inc. (-0.31), less than Aptevo Therapeutics Inc. (-0.19),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.12 | $5.07M | |
| -0.96 | $11.30M | |
| -0.33 | $6.63M | |
| -1.22 | $5.10M | |
| -0.44 | $4.46M | |
| -2.45 | $14.90M | |
| -0.12 | $34.47M | |
| -1.39 | $5.60M | |
| -0.31 | $2.49M | |
| -0.19 | $10.45M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Phio Pharmaceuticals Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Phio Pharmaceuticals Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Phio Pharmaceuticals Corp.'s PE Ratio?
How is the PE Ratio calculated for Phio Pharmaceuticals Corp. (PHIO)?
What is the highest PE Ratio for Phio Pharmaceuticals Corp. (PHIO)?
What is the 3-year average PE Ratio for Phio Pharmaceuticals Corp. (PHIO)?
What is the 5-year average PE Ratio for Phio Pharmaceuticals Corp. (PHIO)?
How does the current PE Ratio for Phio Pharmaceuticals Corp. (PHIO) compare to its historical average?